Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$60.14 - $75.36 $110,056 - $137,908
1,830 Added 2.13%
87,614 $5.69 Million
Q4 2023

Jan 25, 2024

SELL
$42.85 - $69.5 $979,850 - $1.59 Million
-22,867 Reduced 21.05%
85,784 $5.86 Million
Q3 2023

Oct 27, 2023

BUY
$49.5 - $66.6 $5.38 Million - $7.24 Million
108,651 New
108,651 $5.64 Million
Q2 2023

Jul 18, 2023

BUY
$48.54 - $61.64 $385,359 - $489,359
7,939 Added 8.0%
107,138 $6.42 Million
Q1 2023

Apr 13, 2023

BUY
$46.12 - $65.71 $197,900 - $281,961
4,291 Added 4.52%
99,199 $4.9 Million
Q4 2022

Jan 23, 2023

SELL
$45.51 - $65.08 $34,223 - $48,940
-752 Reduced 0.79%
94,908 $0
Q3 2022

Oct 26, 2022

BUY
$37.34 - $57.44 $3.57 Million - $5.49 Million
95,660 New
95,660 $4.49 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.